BioSpace News Archive

Business

Entrepreneur Teams Up with Leading Psychiatrist to Address Depression, Anxiety, and Suicide

Russell Pike, a successful entrepreneur and sports handicapper, is collaborating with renowned forensic psychiatrist Dr. Sanjay Sahgal in addressing the scourge of anxiety, depression, and suicide in our modern-day lives.

June 25, 2018
·
2 min read
Deals

Heron Therapeutics Announces Pricing of Public Offering of Approximately $200 Million of its Common Stock

Heron Therapeutics, Inc. announced the pricing of an underwritten public offering of approximately $200 million of shares of its common stock.

June 25, 2018
·
3 min read
Policy

FCF Fishery, Largest Tuna Supplier in Western Pacific, Granted Marine Stewardship Council Certification

FCF Fishery Company (FCF) and the Western Pacific Sustainable Tuna Alliance announced today that the Western and Central Pacific skipjack and yellowfin free school purse seine fishery has been granted Marine Stewardship Council (MSC) Standard for Sustainable Fishing certification.

June 25, 2018
·
2 min read
Drug Development

Roche’s Tecentriq Scores More Support for Lung Cancer Cocktail

Roche announced that its Phase III IMpower 133 clinical trial of Tecentriq (atezolizumab) plus carboplatin and etoposide chemotherapy met its co-primary endpoints.

June 25, 2018
·
2 min read
·
Mark Terry
Business

AbbVie, Calibr Collaborate to Develop Next-Generation CAR-T Therapies for Solid Tumors

AbbVie is taking another shot at solid tumor treatments through a collaboration with Calibr.

June 25, 2018
·
2 min read
·
Alex Keown
BioMidwest

Akero Therapeutics Launches with $65 Million Series A to Battle NASH

Akero Therapeutics, headquartered in Cambridge, Massachusetts, closed on a $65 million Series A financing round.

June 25, 2018
·
3 min read
·
Mark Terry
NodThera Snags $40 Million in Financing to Target Diseases Driven by Chronic Inflammation

Nodthera, a U.K.-based startup, snagged $40 million (£28 million) in Series A funding.

June 25, 2018
·
2 min read
·
Alex Keown
Pharm Country

FDA Accepts Merck’s Supplemental Application for Keytruda in Advanced Melanoma

The U.S. Food and Drug Administration (FDA) accepted Merck’s new supplemental Biologics License Application (sBLA) for Keytruda.

June 25, 2018
·
3 min read
·
Mark Terry
Genetown

Reconstitution of Russell Indexes Captures Six Biotech Companies

Six biotechs will end the month of June as new additions to the Russell Indexes. Approximately $9 trillion in assets are benchmarked against Russell U.S. Indexes, which are reconstituted annually.

June 25, 2018
·
3 min read
·
Alex Keown
Business

Licensing Deals Struck for Liver Disease and IBD Treatments

This morning two companies announced deals that will yield potential benefits to multiple patient populations.

June 25, 2018
·
2 min read
·
Alex Keown